Ab­b­Vie's Al­ler­gan inks $2.3B+ opi­oid set­tle­ment with sev­er­al states

Less than a week af­ter Te­va inked a $4.25 bil­lion deal to set­tle opi­oid-re­lat­ed lit­i­ga­tion in sev­er­al states, many of the same states are now tout­ing a sim­i­lar deal with Ab­b­Vie.

Ab­b­Vie’s Al­ler­gan unit has agreed to pay up to $2.37 bil­lion (in­clud­ing set­tle­ments al­ready reached with in­di­vid­ual states) to state and lo­cal gov­ern­ments af­fect­ed by the opi­oid cri­sis. To­geth­er with the Te­va deal, that amounts to $6.6 bil­lion in set­tle­ment funds na­tion­wide, ac­cord­ing to state­ments re­leased by sev­er­al at­tor­neys gen­er­al on Fri­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER